Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

Grab BIDU Stock Before It Bounces All the Way Back

By Joel Baglole, InvestorPlace Contributor
After a bruising spring and summer, shares of Chinese technology giant Baidu look to finally be on the mend. After plummeting 30% over the past six months, the company's share price has actually risen 4% since September 1 and now change hands at $164.42 per share. Since bottoming at $137.33 on August 19, the stock has climbed 20% higher.

Cassava Stock Is a Bold Play That Could Pay Off Soon

By Chris Lau, InvestorPlace Contributor
Bears are attacking Cassava as it questions the quality of its clinical data and try to stop its study for treating Alzheimer’s disease.

QuantumScape Stock Is a Good Buy For Investors Who Are Willing to Wait For Results

By David Moadel, InvestorPlace Contributor
QS stock's performance might have disappointed some investors, but future-forward battery technology will be the key to higher share prices.

Jumia Technologies Stock Could Double Or Triple From Here

By David Moadel, InvestorPlace Contributor
Jumia is seeing increased orders and greater market penetration with JumiaPay. In time, these factors should catalyze JMIA stock.

7 Small-Cap Stocks That Are Diamonds in the Rough

By Chris Lau, InvestorPlace Contributor
Small-cap stocks have more upside when investors ignore them, leaving a wide mispricing and a discount big enough for investors. Here are the seven most under-followed companies with the biggest potential upside ahead.

Adobe Is Beating the Market With 1 Weird Trick

By Dana Blankenhorn, InvestorPlace Contributor
Adobe committed itself to Microsoft's cloud a decade ago, making this 40-year-old software company a huge winner with ADBE stock.

7 S&P 500 Dividend Stocks To Buy Yielding 4%  

By Will Ashworth, InvestorPlace Contributor
There are 80 companies in the S&P 500 High Dividend Index ETF. Here are seven dividend stocks to buy from this exchange-traded fund that yield at least 4%.

AMC Entertainment Stock Has Too Much Downside and Hardly Any Upside at All

By Thomas Niel, InvestorPlace Contributor
Bottom line: with more than 87% potential downside, and questionable room to run, stay away from AMC stock.

Novavax Will Enter the Covid-19 Vaccine Race With a Bang

By Muslim Farooque, InvestorPlace Contributor
NVAX stock trades at an attractive price compared with its peers as the market hasn't priced in its long-term growth potential.

4 Top Stock Trades for Monday: NVAX, FCEL, KR, PLAY

By Bret Kenwell, InvestorPlace Contributor
Novavax, FuelCell Energy, Kroger and Dave & Buster's were our top stock trades for Monday. Let's look at the charts after a busy Friday.

7 Virtual Reality Stocks to Buy for the Big Metaverse Move

By Josh Enomoto, InvestorPlace Contributor
With digitalization becoming a core component of our everyday lives, these virtual reality stocks deserve a second look.

3 Stocks Under $100 to Buy and Hold Forever

By David Cohne, StockNews.com
Some investors prefer to buy stocks for the long-term. They should consider these stocks under $100 with sustainable business models.

Buy Intel Before It Brings Chip Production to America

By Dana Blankenhorn, InvestorPlace Contributor
CEO Pat Gelsinger is deftly using the spectre of China to secure subsidies that could make INTC stock the most important security in chips.

Roku May Have a Little Further to Fall, But It’s Still a Growth Stock

By Mark R. Hake, CFA
Roku may have a little further to fall. But ROKU stock could turn around if growth accelerates and as analysts expect the stock to rise again.

Novavax Could Rise 56% Once Its Covid-19 Vaccine Is Approved

By Mark R. Hake, CFA
Novavax is still deeply undervalued. NVAX stock has a good chance of rising to $403.75 once its Covid 19 vaccine rolls out successfully.

7 Biotech Stocks to Buy That Have Millionaire-Maker Potential

By Josh Enomoto, InvestorPlace Contributor
This sector is always a risky area to gamble in. If you have the stomach for it, however, these biotech stocks could see massive gains.

Paysafe Was Too Risky Before Its Decline, but for $8 It’s Worth It

By Tom Kerr, InvestorPlace Contributor
When I last wrote about Paysafe (NYSE:PSFE) in April of this year, I was skeptical of the SPAC craziness in the general sense of bringing…

7 Cathie Wood Stock Favorites to Keep on Your Radar

By Faizan Farooque, InvestorPlace Contributor
Cathie Wood and her funds are generating a lot of interest among investors for smart picks, and these Cathie Wood stocks are worth a look.

3 Top Chinese Stocks to Buy as Regulators Crack Down

By Tezcan Gecgil, InvestorPlace Contributor
A regulatory crackdown in Beijing caused many Chinese stocks to drop, creating new buying opportunities for buy-and-hold investors.
Load More Articles